United States Dabigatran Etexilate Market Report 2016

Publisher Name :
Date: 07-Oct-2016
No. of pages: 122

Notes:

Sales, means the sales volume of Dabigatran Etexilate

Revenue, means the sales value of Dabigatran Etexilate

This report studies sales (consumption) of Dabigatran Etexilate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Dabigatran Etexilate in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Dabigatran Etexilate Market Report 2016

Table of Contents
United States Dabigatran Etexilate Market Report 2016
1 Dabigatran Etexilate Overview
1.1 Product Overview and Scope of Dabigatran Etexilate
1.2 Classification of Dabigatran Etexilate
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Dabigatran Etexilate
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Dabigatran Etexilate (2011-2021)
1.4.1 United States Dabigatran Etexilate Sales and Growth Rate (2011-2021)
1.4.2 United States Dabigatran Etexilate Revenue and Growth Rate (2011-2021)
2 United States Dabigatran Etexilate Competition by Manufacturers
2.1 United States Dabigatran Etexilate Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Dabigatran Etexilate Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Dabigatran Etexilate Average Price by Manufactures (2015 and 2016)
2.4 Dabigatran Etexilate Market Competitive Situation and Trends
2.4.1 Dabigatran Etexilate Market Concentration Rate
2.4.2 Dabigatran Etexilate Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Dabigatran Etexilate Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Dabigatran Etexilate Sales and Market Share by Type (2011-2016)
3.2 United States Dabigatran Etexilate Revenue and Market Share by Type (2011-2016)
3.3 United States Dabigatran Etexilate Price by Type (2011-2016)
3.4 United States Dabigatran Etexilate Sales Growth Rate by Type (2011-2016)
4 United States Dabigatran Etexilate Sales (Volume) by Application (2011-2016)
4.1 United States Dabigatran Etexilate Sales and Market Share by Application (2011-2016)
4.2 United States Dabigatran Etexilate Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Dabigatran Etexilate Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Dabigatran Etexilate Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Dabigatran Etexilate Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Dabigatran Etexilate Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Dabigatran Etexilate Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Dabigatran Etexilate Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Dabigatran Etexilate Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Dabigatran Etexilate Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Dabigatran Etexilate Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Dabigatran Etexilate Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Dabigatran Etexilate Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Dabigatran Etexilate Manufacturing Cost Analysis
6.1 Dabigatran Etexilate Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Dabigatran Etexilate
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Dabigatran Etexilate Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Dabigatran Etexilate Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Dabigatran Etexilate Market Forecast (2016-2021)
10.1 United States Dabigatran Etexilate Sales, Revenue Forecast (2016-2021)
10.2 United States Dabigatran Etexilate Sales Forecast by Type (2016-2021)
10.3 United States Dabigatran Etexilate Sales Forecast by Application (2016-2021)
10.4 Dabigatran Etexilate Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Dabigatran Etexilate
Table Classification of Dabigatran Etexilate
Figure United States Sales Market Share of Dabigatran Etexilate by Type in 2015
Table Application of Dabigatran Etexilate
Figure United States Sales Market Share of Dabigatran Etexilate by Application in 2015
Figure United States Dabigatran Etexilate Sales and Growth Rate (2011-2021)
Figure United States Dabigatran Etexilate Revenue and Growth Rate (2011-2021)
Table United States Dabigatran Etexilate Sales of Key Manufacturers (2015 and 2016)
Table United States Dabigatran Etexilate Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Dabigatran Etexilate Sales Share by Manufacturers
Figure 2016 Dabigatran Etexilate Sales Share by Manufacturers
Table United States Dabigatran Etexilate Revenue by Manufacturers (2015 and 2016)
Table United States Dabigatran Etexilate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Dabigatran Etexilate Revenue Share by Manufacturers
Table 2016 United States Dabigatran Etexilate Revenue Share by Manufacturers
Table United States Market Dabigatran Etexilate Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Dabigatran Etexilate Average Price of Key Manufacturers in 2015
Figure Dabigatran Etexilate Market Share of Top 3 Manufacturers
Figure Dabigatran Etexilate Market Share of Top 5 Manufacturers
Table United States Dabigatran Etexilate Sales by Type (2011-2016)
Table United States Dabigatran Etexilate Sales Share by Type (2011-2016)
Figure United States Dabigatran Etexilate Sales Market Share by Type in 2015
Table United States Dabigatran Etexilate Revenue and Market Share by Type (2011-2016)
Table United States Dabigatran Etexilate Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Dabigatran Etexilate by Type (2011-2016)
Table United States Dabigatran Etexilate Price by Type (2011-2016)
Figure United States Dabigatran Etexilate Sales Growth Rate by Type (2011-2016)
Table United States Dabigatran Etexilate Sales by Application (2011-2016)
Table United States Dabigatran Etexilate Sales Market Share by Application (2011-2016)
Figure United States Dabigatran Etexilate Sales Market Share by Application in 2015
Table United States Dabigatran Etexilate Sales Growth Rate by Application (2011-2016)
Figure United States Dabigatran Etexilate Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Dabigatran Etexilate Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Dabigatran Etexilate Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dabigatran Etexilate
Figure Manufacturing Process Analysis of Dabigatran Etexilate
Figure Dabigatran Etexilate Industrial Chain Analysis
Table Raw Materials Sources of Dabigatran Etexilate Major Manufacturers in 2015
Table Major Buyers of Dabigatran Etexilate
Table Distributors/Traders List
Figure United States Dabigatran Etexilate Production and Growth Rate Forecast (2016-2021)
Figure United States Dabigatran Etexilate Revenue and Growth Rate Forecast (2016-2021)
Table United States Dabigatran Etexilate Production Forecast by Type (2016-2021)
Table United States Dabigatran Etexilate Consumption Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United States Home Telemonitoring Systems Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 95
    Notes: Sales, means the sales volume of Home Telemonitoring Systems Revenue, means the sales value of Home Telemonitoring Systems This report studies sales (consumption) of Home Telemonitoring Systems in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott - Cisco Systems - DigiO2 International - GE Healthcare - Honeywell HomeMed - Mindray Medical Int......
  • United States Cardiac Event Monitors Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 99
    Notes: Sales, means the sales volume of Cardiac Event Monitors Revenue, means the sales value of Cardiac Event Monitors This report studies sales (consumption) of Cardiac Event Monitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Medtronic PLC - St. Jude Medical, Inc. - Boston Scientific Corporation - GE Healthcare - Philips Healthcare - Biotroni......
  • United States Medical Image Sensors Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 110
    Notes: Sales, means the sales volume of Medical Image Sensors Revenue, means the sales value of Medical Image Sensors This report studies sales (consumption) of Medical Image Sensors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Honeywell - TE Connectivity - NovaSensor - AMS AG - Tekscan - Measurement Specialties - Sysmex - AMETEK......
  • United States Infusion Manifold Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Infusion Manifold Revenue, means the sales value of Infusion Manifold This report studies sales (consumption) of Infusion Manifold in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - B. Braun Medical Ltd - Smiths Medical - ACE Medical - Bicakcilar - Asept Inmed - Merit Medical Systems - Perouse Medical......
  • United States Circulating Tumor Cells (CTCs) Detectors Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Circulating Tumor Cells (CTCs) Detectors Revenue, means the sales value of Circulating Tumor Cells (CTCs) Detectors This report studies sales (consumption) of Circulating Tumor Cells (CTCs) Detectors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Johnson & Johnson - Epic Sciences - On-chip - CytoTrack - Qiagen ......
  • United States Arteriotomy Closure Devices Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 95
    Notes: Sales, means the sales volume of Arteriotomy Closure Devices Revenue, means the sales value of Arteriotomy Closure Devices This report studies sales (consumption) of Arteriotomy Closure Devices in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott Vascular - St. Jude Medical - Cardinal Health - Arstasis - Cardiva Medical - Vasorum ......
  • United States Urinalysis Analyzer Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Urinalysis Analyzer Revenue, means the sales value of Urinalysis Analyzer This report studies sales (consumption) of Urinalysis Analyzer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Beckman Coulter - Roche Diagnostics - Siemens AG - Sysmex Corporation Market Segment by States, covering - California......
  • United States Carotid Artery Stent Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 110
    Notes: Sales, means the sales volume of Carotid Artery Stent Revenue, means the sales value of Carotid Artery Stent This report studies sales (consumption) of Carotid Artery Stent in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott Laboratories - Omron - Advanced Cardiac Therapeutics - Carmat - Volcano - AtriCure - Berlin Heart - Bio......
  • Global X-Ray Bone Densitometer Sales Market Report 2017
    Published: 27-Feb-2017        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of X-Ray Bone Densitometer Revenue, means the sales value of X-Ray Bone Densitometer This report studies sales (consumption) of X-Ray Bone Densitometer in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GE Healthcare - Hologic - Osteosys - DMS......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs